{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:07:59Z","timestamp":1791479279821,"version":"4.3.4"},"reference-count":122,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jconrel.2012.01.020","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T16:02:11Z","timestamp":1327852931000},"page":"389-398","source":"Crossref","is-referenced-by-count":63,"title":["The impact of ageing on the barriers to drug delivery"],"prefix":"10.1016","volume":"161","author":[{"given":"Yvonne","family":"Perrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj K. Singh","family":"Badhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal R.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jconrel.2012.01.020_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0026-0495(03)00298-1","article-title":"Drug therapy in the elderly","volume":"52","author":"Noble","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/gut.4.2.136","article-title":"Studies of basal and peak acid output with an augmented histamine test","volume":"4","author":"Baron","year":"1963","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/00365528209181087","article-title":"Age- and sex-related behaviour of gastric acid secretion at the population level","volume":"17","author":"Kekki","year":"1982","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1532-5415.1981.tb01766.x","article-title":"Gastric emptying rate in the elderly: implications for drug therapy","volume":"29","author":"Evans","year":"1981","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1532-5415.1965.tb02665.x","article-title":"The effect of increasing age on the distribution of peripheral blood flow in man","volume":"16","author":"Bender","year":"1965","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0595","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(78)92639-9","article-title":"Age changes in small-intestinal mucosa","volume":"2","author":"Warren","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0169-409X(97)00041-0","article-title":"The barrier function of CYP3A4 and P-glycoprotein in the small bowel","volume":"27","author":"Watkins","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"13","key":"10.1016\/j.jconrel.2012.01.020_bb0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mc.2940130302","article-title":"Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy","volume":"1995","author":"Wacher","year":"1995","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0600","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000065506","article-title":"Aging liver","volume":"48","author":"Anantharaju","year":"2002","journal-title":"Rev. Gerontol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000138369","article-title":"Antipyrine absorption and disposition in the elderly","volume":"36","author":"Greenblatt","year":"1988","journal-title":"Pharmacology"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.1975.tb02774.x","article-title":"The effect of age on plasma levels of propranolol and practolol in man","volume":"2","author":"Castleden","year":"1975","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0060","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1532-5415.1982.tb07093.x","article-title":"Age does not alter acetaminophen absorption","volume":"30","author":"Divoll","year":"1982","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0065","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2165\/00003088-198917040-00003","article-title":"Clinical pharmacokinetic considerations in the elderly. An update","volume":"17","author":"Dawling","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00002512-199813050-00003","article-title":"Drug dosage in the elderly. Is it rational?","volume":"13","author":"Turnheim","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0605","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1302::AID-CNCR16>3.0.CO;2-B","article-title":"Aging and pharmacology","volume":"80","author":"Vestal","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/geronj\/43.1.M18","article-title":"The effect of age on serum albumin in healthy males: report from the Normative Aging Study","volume":"43","author":"Campion","year":"1988","journal-title":"J. Gerontol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/j.1552-4604.1982.tb02671.x","article-title":"Importance of protein binding for the interpretation of serum or plasma drug concentrations","volume":"22","author":"Greenblatt","year":"1982","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000212209","article-title":"Protein intake and serum albumin levels in the elderly","volume":"23","author":"MacLennan","year":"1977","journal-title":"Gerontology"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0610","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1532-5415.1979.tb01715.x","article-title":"Reduced serum albumin concentration in the elderly: report from the Boston. Collaborative Drug Surveillance Program","volume":"27","author":"Greenblatt","year":"1979","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-198712010-00004","article-title":"Plasma protein binding of drugs in the elderly","volume":"12","author":"Wallace","year":"1987","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2125.1975.tb00474.x","article-title":"Changes in drug metabolism with increasing age: 1. Warfarin binding and plasma proteins","volume":"2","author":"Hayes","year":"1975","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0031-6997(25)06825-5","article-title":"Aging and drug disposition: an update","volume":"37","author":"Schmucker","year":"1985","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0615","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199834050-00003","article-title":"The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis","volume":"34","author":"Le Couteur","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0620","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/bmj.3.5775.607","article-title":"Effect of age and sex on human drug metabolism","volume":"3","author":"O'Malley","year":"1971","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00607447","volume":"14","author":"Swift","year":"1978","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0135","series-title":"Cytochromes P450: Metabolic and Toxicological Aspects","first-page":"241","article-title":"The CYP3A family","author":"Maurel","year":"1996"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0625","first-page":"415","article-title":"Antipyrine disposition and liver size in the elderly","volume":"51","author":"Johnson","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0145","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/j.1552-4604.1979.tb01646.x","article-title":"Digitalis delirium in elderly patients","volume":"19","author":"Portnoi","year":"1979","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2165\/00003088-199324050-00007","article-title":"Pharmacokinetics of indomethacin in the elderly","volume":"24","author":"Oberbauer","year":"1993","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2125.1982.tb04947.x","article-title":"Pharmacokinetics of azapropazone in the elderly","volume":"14","author":"Ritch","year":"1982","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2125.1977.tb00694.x","article-title":"Pharmacokinetics of azapropazone in the elderly","volume":"4","author":"Hewick","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0630","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arr.2010.04.005","article-title":"Geriatric drug therapy: neglecting the inevitable majority","volume":"9","author":"Stegemann","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0635","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0016-5085(99)70144-7","article-title":"AGA technical review on management of oropharyngeal dysphagia","volume":"116","author":"Cook","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0175","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1651-2227.1999.tb00191.x","article-title":"Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study","volume":"88","author":"Turner","year":"1999","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0180","first-page":"584","article-title":"Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10mg tablets","volume":"44","author":"Cook","year":"2003","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0640","first-page":"28","article-title":"Time to strengthen the evidence base for paediatric formulations","volume":"3","author":"Kirby","year":"2011","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ejpb.2006.11.018","article-title":"Quinine sulphate pellets for flexible pediatric drug dosing: formulation development and evaluation of taste-masking efficiency using the electronic tongue","volume":"66","author":"Kayumba","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijpharm.2006.03.018","article-title":"Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking","volume":"318","author":"Gao","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2010.05.007","article-title":"Optimization of a novel wax matrix system using aminoalkyl methacrylate copolymer E and ethylcellulose to suppress the bitter taste of acetaminophen","volume":"395","author":"Shini","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0645","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(99)00261-6","article-title":"An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part 1: the influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres","volume":"190","author":"Robson","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(99)00391-9","article-title":"An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release","volume":"195","author":"Robson","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0650","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.actbio.2010.03.013","article-title":"Novel thermosensitive calcium alginate microspheres: physico-chemical characterization and delivery properties","volume":"6","author":"Oddo","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0655","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/S1359-6446(04)03351-3","article-title":"Formulation strategies for absorption windows","volume":"10","author":"Davis","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1006469621561","article-title":"The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery","volume":"18","author":"Bardelmeijer","year":"2000","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0230","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.27.8.886","article-title":"Transit of pharmaceutical dosage forms through the small intestine","volume":"27","author":"Davis","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0660","article-title":"Physiological Pharmaceutics, Barriers to Drug Absorption","author":"Washington","year":"2001"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0665","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-5173(96)85200-8","article-title":"Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery","volume":"136","author":"Rouge","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-3659(99)00204-7","article-title":"Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention","volume":"63","author":"Singh","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0250","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1645\/GE-3307","article-title":"Guanosine 3\u2032,5\u2032-cyclic monophosphate: a tapeworm-secreted signal molecule communicating with the rat host's small intestine","volume":"89","author":"Kroening","year":"2003","journal-title":"J. Parasitol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0255","first-page":"313","article-title":"The potential of fimbrial proteins for delaying intestinal transit of oral drug delivery systems","volume":"17","author":"Caston","year":"1990","journal-title":"Proc. Intern Symp. Control Rel. Bioact. Mater"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0670","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1023\/A:1011044730790","article-title":"Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats","volume":"18","author":"Montisci","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0675","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/oxfordjournals.aje.a009609","article-title":"International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"148","author":"Morabia","year":"1998","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0270","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1742-1241.2010.02355.x","article-title":"A practical guide to male hypogonadism in the primary care setting","volume":"64","author":"Dandona","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0275","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000175842","article-title":"Advances in testosterone replacement therapy","volume":"37","author":"Gooren","year":"2009","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0280","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1461-5347(00)00295-9","article-title":"Transdermal drug delivery: overcoming the skin's barrier function","volume":"3","author":"Naik","year":"2000","journal-title":"Pharm Sci Technol To"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0285","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.urology.2005.11.039","article-title":"Transdermal delivery of drugs for urologic applications: basic principles and applications","volume":"67","author":"Nitti","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0680","series-title":"Dermal Adsorption","author":"Kielhorn","year":"2006"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0169-409X(00)00062-4","article-title":"Transdermal delivery of drugs for the treatment of bone diseases","volume":"42","author":"Ramachandran","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0685","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1152\/physrev.1971.51.4.702","article-title":"Permeability of the skin","volume":"41","author":"Scheuplein","year":"1971","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0690","series-title":"Dermal Adsorption","article-title":"Skin structure and function","author":"Singh","year":"2006"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0695","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12325-009-0075-9","article-title":"Skin tolerability associated with transdermal drug delivery systems: an overview","volume":"26","author":"Ale","year":"2009","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0315","series-title":"Marzulli and Maibach's Dermato-Toxicology","first-page":"101","article-title":"Transdermal drug delivery system: an overview","author":"Levin","year":"2008"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0320","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00002512-200825040-00001","article-title":"Use of transdermal drug formulations in the elderly","volume":"2594","author":"Kaestli","year":"2008","journal-title":"Drug Aging"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0700","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/thx.17.4.329","article-title":"Postnatal growth of the lung","volume":"17","author":"Dunnill","year":"1962","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jconrel.2012.01.020_bb0330","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM197006042822302","article-title":"Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease","volume":"28","author":"Hogg","year":"1970","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2012.01.020_bb0335","first-page":"552","article-title":"Studies on elastic recoil of the lung in a pediatric population","volume":"10","author":"Stigol","year":"1972","journal-title":"Am. Rev. Respir. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2012.01.020_bb0340","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/thx.22.6.483","article-title":"Internal surface area and other measurements in emphysema","volume":"2","author":"Thurlbeck","year":"1967","journal-title":"Thorax"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0705","first-page":"195","article-title":"Frequent dependence of compliance in apparently healthy smokers versus non-smokers","volume":"7","author":"Ingram","year":"1971","journal-title":"Physio-Pathol. Respir."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0350","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/thx.20.5.469","article-title":"Biochemistry of aging in the lung, in aging of the lung","volume":"2","author":"Pierce","year":"1965","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.jconrel.2012.01.020_bb0355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/bj1270261","article-title":"Chemical composition of elastins isolated from aortas and pulmonary tissues of humans of different ages","volume":"12","author":"John","year":"1972","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0360","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1152\/jappl.1971.30.6.874","article-title":"Length-tension properties of alveolar wall in man","volume":"3","author":"Sugihara","year":"1971","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0365","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0954-6111(98)90190-1","article-title":"Spirometric reference equations for older adults","volume":"92","author":"McDonnell","year":"1998","journal-title":"Respir. Med."},{"issue":"9","key":"10.1016\/j.jconrel.2012.01.020_bb0370","first-page":"727","article-title":"The effect of patent ductus arteriousus and of interauricular and interventricular septal defects on the development of pulmonary vascular lesions","volume":"2","author":"Welch","year":"1948","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.jconrel.2012.01.020_bb0375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0007-0971(70)80030-4","article-title":"The pulmonary artery in the normal aged lung","volume":"6","author":"Semmens","year":"1970","journal-title":"Br. J. Dis. Chest"},{"issue":"8","key":"10.1016\/j.jconrel.2012.01.020_bb0380","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1579-2129(09)72935-0","article-title":"Relation between atherosclerotic calcifications detected in chest computed tomography and lung function","volume":"45","author":"Tapio","year":"2009","journal-title":"Arch. Bronconeumol. (English Edition)"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0710","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1378\/chest.114.6.1704","article-title":"Geriatric respiratory medicine","volume":"114","author":"Chan","year":"1998","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jconrel.2012.01.020_bb0715","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0378-5173(95)04326-8","volume":"130","author":"Boer (a)","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2012.01.020_bb0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5173(97)00097-5","article-title":"Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers: Part 3: the effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler","volume":"153","author":"Boer","year":"1997","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2012.01.020_bb0400","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5173(96)04526-7","article-title":"Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers Part 2: effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers","volume":"138","author":"Boer","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0405","first-page":"329","article-title":"Kokyu TO Junkan Pulmonary gas exchange function of supine elderly subjects in relation to closing volumes","volume":"24","author":"Ohtsuka","year":"1976","journal-title":"Respir. Circ."},{"issue":"1","key":"10.1016\/j.jconrel.2012.01.020_bb0410","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2003.07.002","article-title":"Lung infections and aging","volume":"3","author":"Meyer","year":"2004","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.jconrel.2012.01.020_bb0415","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.rmed.2005.03.023","article-title":"Lung function in type 2 diabetes: the Normative Aging Study","volume":"99","author":"Litonjua","year":"2005","journal-title":"Respir. Med."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0720","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.93.04030279","article-title":"Relationships between lung function and physical characteristics in young adult black and white males and females","volume":"4","author":"McDonnell","year":"1991","journal-title":"Eur. Respir."},{"issue":"3","key":"10.1016\/j.jconrel.2012.01.020_bb0725","first-page":"56","article-title":"Protection of the lungs from acid during aspiration","volume":"1","author":"Richard","year":"2001","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2012.01.020_bb0730","first-page":"3","article-title":"Mechanisms of macromolecule absorption by the lungs, advanced drug delivery reviews","volume":"19","author":"Patton","year":"1996","journal-title":"Pulm. Polypeptide Polynucleic Acid Deliv."},{"issue":"11","key":"10.1016\/j.jconrel.2012.01.020_bb0735","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.acra.2005.08.005","article-title":"Detection of age-dependent changes in healthy adult lungs with diffusion-weighted 3He MRI","volume":"12","author":"Sean","year":"2005","journal-title":"Acad. Radiol."},{"issue":"2","key":"10.1016\/j.jconrel.2012.01.020_bb0440","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.freeradbiomed.2010.11.013","article-title":"The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic inflammation","volume":"50","author":"Starr","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0740","volume":"77","author":"Schleh","year":"2011","journal-title":"J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jconrel.2012.01.020_bb0745","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0952-7915(99)80006-5","article-title":"The influence of pulmonary surfactant on nanoparticle drug delivery systems","volume":"11","author":"Eggleton","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0455","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1164\/ajrccm\/141.2.471","article-title":"Macrophages and polymorphonnuclear neutophils in lung defense and injury","volume":"141","author":"Sibille","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2012.01.020_bb0460","first-page":"58","article-title":"The ageing eye \u2014 threats to vision and their treatments","volume":"10","author":"Welch","year":"2008","journal-title":"CME J. Geriatr. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2012.01.020_bb0465","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.5.5.567","article-title":"Ocular novel drug delivery: impacts of membranes and barriers","volume":"5","author":"Barar","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0470","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0750","doi-asserted-by":"crossref","first-page":"E820","DOI":"10.1208\/aapsj070479","volume":"7","author":"Bodor","year":"2005","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0755","first-page":"171","volume":"4","author":"Mather","year":"2010","journal-title":"Cont. Lens Anterior Eye"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0760","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clae.2010.02.003","volume":"4","author":"Maissa","year":"2010","journal-title":"Cont Les Anterior eye"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0765","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0169-409X(98)00055-6","article-title":"Cyclodextrins in ophthalmic drug delivery","volume":"36","author":"Loftssona","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0770","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2007.07.009","article-title":"In situ-forming hydrogels for sustained ophthalmic drug delivery","volume":"122","author":"Nanjawade","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0775","unstructured":"Cyclosporin \u2013 allergan. Ciclosporin \u2013 allergan, cyclosporin opthalmic emulsion, cyclosporine = Allergan, Restatis. Drugs R D. 4 (2) (2003) 126\u2013127. PMID:12718570."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0505","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0169-409X(95)00014-X","article-title":"Ocular inserts for topical delivery","volume":"16","author":"Saettone","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0510","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/08820530902802161","article-title":"Contact lenses for drug delivery","volume":"24","author":"Ciolino","year":"2009","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0780","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11095-009-0042-9","article-title":"New techniques for drug delivery to the posterior eye segment","volume":"27","author":"Eljarrat-Binstock","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0520","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000209665","article-title":"Drug delivery systems for retinal diseases. A review","volume":"41","author":"Lee","year":"2009","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0525","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/jps.21987","article-title":"A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases","volume":"99","author":"Choonara","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0530","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.addr.2006.07.026","article-title":"Intraocular implants for extended drug delivery: therapeutic applications","volume":"58","author":"Bourges","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0535","first-page":"386","article-title":"The new non-HIV antivirals and antifungals: review and assessment for the formulary","volume":"32","author":"Flores","year":"1997","journal-title":"Formulary"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0540","first-page":"1159","article-title":"Retisert Bausch & Lomb\/control delivery systems","volume":"6","author":"Lim","year":"2005","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0785","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable implants for sustained drug release in the eye","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0790","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0555","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/IAE.0b013e318042b53f","article-title":"Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration","volume":"27","author":"Goff","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0560","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration","volume":"26","author":"Ferrara","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0795","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.jconrel.2012.01.020_bb0570","first-page":"11","article-title":"Recent trends in the developments of orally disintegrating tablet technology","volume":"40","author":"Kundu","year":"2008","journal-title":"Pharma Times"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0800","unstructured":"F Liu, MM He, JR Nyshadham, K Sharma, JS Chu, P Alto, JA Fix. Water Soluble Polymer-Based Rapidly Dissolving Tablets and Production Process thereof, US patent (2003), 0,129,226 A1"},{"issue":"6","key":"10.1016\/j.jconrel.2012.01.020_bb0805","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i6.10","article-title":"Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies","volume":"21","author":"Fu","year":"2004","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"3","key":"10.1016\/j.jconrel.2012.01.020_bb0585","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejpb.2011.05.014","article-title":"Formulation of multiparticulate systems as lyophilised orally disintegrating tablets","volume":"79","author":"AlHusban","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0590","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0016-5085(99)70144-7","article-title":"Review on management of oropharyngeal dysphagia","volume":"116","author":"Cook","year":"1999","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jconrel.2012.01.020_bb0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics2010001","article-title":"Investigation of formulation and process of lyophilised orally disintegrating tablet (ODT) using novel amino acid combination","volume":"2","author":"AlHusban","year":"2010","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2012.01.020_bb0815","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejpb.2010.03.012","article-title":"Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents","volume":"75","author":"AlHusban","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2012.01.020_bb0820","unstructured":"Y Fu, C Pai, SY Park, G Seomoon, K Park. Highly Plastic Granules for Making Fast Melting Tablets. US patent (2005), 0,013,857 A1"},{"key":"10.1016\/j.jconrel.2012.01.020_bb0825","unstructured":"JP Remon, and S Corveleyn, Freeze-Dried Disintegrating Tablets, US patent (2000), 6,010,719."},{"issue":"12","key":"10.1016\/j.jconrel.2012.01.020_bb0830","first-page":"15","article-title":"Impact of ageing","volume":"23","author":"Jessop","year":"2011","journal-title":"Pharm. Technol. Eur."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:58:35Z","timestamp":1742381915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365912000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0168365912000259"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.020","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}